Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_assertion type Assertion NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_head.
- NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_assertion description "[After 2 years, CC carriers had more progression of diffuse and focal atherosclerosis compared with AA carriers, as indicated by a larger decrease in MSD (mean segment diameter; 0.09 mm compared with 0.06 mm respectively; P=0.009) and MOD (minimum obstruction diameter; 0.09 mm compared with 0.05 mm respectively; P=0.024).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_provenance.
- NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_assertion evidence source_evidence_literature NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_provenance.
- NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_assertion SIO_000772 15707388 NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_provenance.
- NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_assertion wasDerivedFrom befree-20140225 NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_provenance.
- NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_assertion wasGeneratedBy ECO_0000203 NP842157.RADKEDf4ylLNKrNmuo-pyTG5rKEOjM2ZzmomtZHaFTzdg130_provenance.